Cargando…
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
BACKGROUND: In the context of recent guidelines on invasive candidiasis (IC), how French intensive care units (ICUs) are managing IC? METHODS: This is a prospective observational multicenter cohort study. During 1 year (2012–2013), 87 French ICUs enrolled consecutive patients with suspected or prove...
Autores principales: | Leroy, Olivier, Bailly, Sébastien, Gangneux, Jean-Pierre, Mira, Jean-Paul, Devos, Patrick, Dupont, Hervé, Montravers, Philippe, Perrigault, Pierre-François, Constantin, Jean-Michel, Guillemot, Didier, Azoulay, Elie, Lortholary, Olivier, Bensoussan, Caroline, Timsit, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Paris
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705061/ https://www.ncbi.nlm.nih.gov/pubmed/26743881 http://dx.doi.org/10.1186/s13613-015-0103-7 |
Ejemplares similares
-
Clinical Impact of Antifungal Susceptibility, Biofilm Formation and Mannoside Expression of Candida Yeasts on the Outcome of Invasive Candidiasis in ICU: An Ancillary Study on the Prospective AmarCAND2 Cohort
por: Gangneux, Jean-Pierre, et al.
Publicado: (2018) -
Antifungal De-Escalation Is Safe in Critically Ill Patients Treated For Suspected Or Documented Invasive Candidiasis. Data From The Amarcand2 Study
por: Bailly, S, et al.
Publicado: (2015) -
Epidemiological cohort study of systemic antifungal therapy for suspected or confirmed invasive candidiasis in the ICU: the Amarcand2 study
por: Constantin, J, et al.
Publicado: (2015) -
Comparison of albicans vs. non-albicans candidemia in French intensive care units
por: Leroy, Olivier, et al.
Publicado: (2010) -
EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial
por: Timsit, Jean-François, et al.
Publicado: (2013)